Sofia Enhörning
1 – 10 of 35
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
The association of copeptin with metabolic risk markers is modified by region of origin
(
- Contribution to journal › Article
- 2022
-
Mark
Seasonal variation of vasopressin and its relevance for the winter peak of cardiometabolic disease : A pooled analysis of five cohorts
(
- Contribution to journal › Article
-
Mark
Germline Mutations in CIDEB and Protection against Liver Disease
(
- Contribution to journal › Article
- 2021
-
Mark
Copeptin as a marker of atherosclerosis and arteriosclerosis
(
- Contribution to journal › Article
-
Mark
Copeptin as a predictive marker of incident heart failure
(
- Contribution to journal › Article
-
Mark
Investigation of possible underlying mechanisms behind water-induced glucose reduction in adults with high copeptin
(
- Contribution to journal › Article
- 2020
-
Mark
High water intake and low urine osmolality are associated with favorable metabolic profile at a population level : low vasopressin secretion as a possible explanation
(
- Contribution to journal › Article
-
Mark
Comparing Self-Reported Sugar Intake With the Sucrose and Fructose Biomarker From Overnight Urine Samples in Relation to Cardiometabolic Risk Factors
(
- Contribution to journal › Article
-
Mark
Response to Letter to the Editor : "Water Supplementation Reduces Copeptin and Plasma Glucose in Adults with High Copeptin: The H2O Metabolism Pilot Study"
(
- Contribution to journal › Debate/Note/Editorial
- 2019
-
Mark
Copeptin relates to a fatty liver and measures of obesity in a South African population with mixed ethnicities
(
- Contribution to journal › Article